Nov 7, 2008 - Winston Laboratories, Inc., a wholly owned subsidiary of Getting Ready Corporation (OTC: GTRY.OB), announced that on October 30, 2008 it entered into a licensing agreement with sanofi-aventis Canada Inc. for the Canadian rights to Winston's proprietary transient receptor potential vanilloid (TRPV-1) modulator in formulations for topical application.
The details can be read here.
No comments:
Post a Comment